Curis (CRIS) EV to CFO (2010 - 2026)
Curis' (CRIS) quarterly EV to CFO came in at 0.48 in Q2 2026, down 57.03% on a YoY basis from 1.11 in Q2 2025, and down 70.32% quarter-over-quarter from 1.61 in Q1 2026.
Analysis
Curis (CRIS) EV to CFO (2010 - 2026) Analysis & Trends
Curis (CRIS) has reported EV to CFO for 17 consecutive years, with 0.48 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EV to CFO fell 57.03% year-over-year to 0.48; the trailing twelve-month figure through Jun 2026 stood at 0.15 (down 48.47% YoY), and the FY2025 full-year result was 0.16, down 66.2% from the prior year.
- EV to CFO fell to 0.48 in Q2 2026 per CRIS's latest filing, from 1.61 in the prior quarter.
- Across five years, EV to CFO topped out at 8.46 in Q2 2022 and bottomed at 0.48 in Q2 2026.
- Historically, EV to CFO has averaged 4.11 across 5 years, with a median of 3.04 in 2024.
- The sharpest annual moves came in 2023 and 2024: EV to CFO gained 12.01% in 2023, then slumped 68.67% in 2024.
- Over 5 years, EV to CFO stood at 6.76 in 2022, then fell by 23.68% to 5.16 in 2023, then plunged by 60.18% to 2.06 in 2024, then tumbled by 66.22% to 0.69 in 2025, then plunged by 31.25% to 0.48 in 2026.
- According to Business Quant data, EV to CFO over the past three periods registered 0.48, 1.61, and 0.69 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | Curis | 2.63 Mn | -2.99 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.48 |
| Mar 31, 2026 | 1.61 |
| Dec 31, 2025 | 0.69 |
| Sep 30, 2025 | 1.44 |
| Jun 30, 2025 | 1.11 |
| Mar 31, 2025 | 2.67 |
| Dec 31, 2024 | 2.06 |
| Sep 30, 2024 | 3.24 |
| Jun 30, 2024 | 2.36 |
| Mar 31, 2024 | 2.84 |
| Dec 31, 2023 | 5.16 |
| Sep 30, 2023 | 8.14 |
| Jun 30, 2023 | 7.55 |
| Mar 31, 2023 | 5.65 |
| Dec 31, 2022 | 6.76 |
| Sep 30, 2022 | 7.26 |
| Jun 30, 2022 | 8.46 |
| Mar 31, 2022 | 6.53 |
| Dec 31, 2021 | 11.51 |
| Sep 30, 2021 | 9.68 |